China BCT Pharmacy Group, Inc. - FORM 10-K/A - EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002. * - October 9, 2012

Attached files

file filename
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A) AND 15D-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. * - China BCT Pharmacy Group, Inc.f10k2011a4ex31ii_chinabct.htm
10-K/A - ANNUAL REPORT - China BCT Pharmacy Group, Inc.f10k2011a4_chinabct.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A) AND 15D-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. * - China BCT Pharmacy Group, Inc.f10k2011a4ex31i_chinabct.htm
EX-32.2 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002. * - China BCT Pharmacy Group, Inc.f10k2011a4ex32ii_chinabct.htm
EXHIBIT 32.1
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with Amendment No. 4 to our Annual Report on Form 10-K/A of China BCT Pharmacy Group, Inc. (the "Company") for the period ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Hui Tian Tang, Chief Executive Officer of the Company, certify, pursuant to Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

 
(1)
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
/s/ Huitian Tang
  
Huitian Tang
  
Chief Executive Officer
  

Dated: October 9, 2012

China BCT Pharmacy Group, Inc. Reports